NCT07004426Completed
Symptomatic and Incidental RCC Detection
Assessment of Symptomatic and Incidental Detection of Renal Cell Carcinoma Using Standard Imaging Modalities
Source: ClinicalTrials.gov · Last updated 19 Mar 2026
Brief summary (registry, in English)
Evaluation of the frequency of symptomatic and incidental detection of renal carcinoma at different stages depending on the imaging modality used
- Status (registry)
- Completed
- Study type
- Observational
- Enrollment
- 1000 (actual)
- First submitted
- 27 May 2025
- Start date
- 1 Jun 2025
- Primary completion date
- 1 Jul 2025
- Lead sponsor
- Charles University, Czech Republic
- Diseases
- Kidney cancer
- NCT number
- NCT07004426
What you commit to
- Study type: Observational
- Participants enrolled: 1000
- From 1 Jun 2025 to the primary completion date, 1 Jul 2025
- 1 site in 1 country
- Visits and tests: ask the trial team, the registry does not list them
Built from the registry fields of ClinicalTrials.gov. It describes the study, not your situation.
Who cannot take part
Copied verbatim from ClinicalTrials.gov and grouped by topic. Only the trial team decides who can take part.
Prior treatment
- patients undergoing surgery for non-renal and urotelial carcinoma, including unknown
Other
- patients with recurrent renal lesions
Who the study is looking for
- patients over 18 years of age undergoing surgical treatment for renal lesions
Age in the registry: 18 years to 90 years · Sex: All · Does not accept healthy volunteers
Sites (1)
Sites in registry order. Pick your city on the disease page to sort them by distance.
| Site | City | Country | Site status |
|---|---|---|---|
| University Hospital Kralovske Vinohrady Coordinator of this site? Confirm its status | Prague | Czechia | Unknown status |
This page is information, not medical advice. Discuss any trial with your doctor.